Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to mani...
Main Authors: | Yan-Ruide Li, Tyler Halladay, Lili Yang |
---|---|
格式: | Article |
語言: | English |
出版: |
BMC
2024-01-01
|
叢編: | Journal of Biomedical Science |
主題: | |
在線閱讀: | https://doi.org/10.1186/s12929-024-00998-8 |
相似書籍
-
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
由: Yan-Ruide Li, et al.
出版: (2022-05-01) -
Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
由: Abigail Cheever, et al.
出版: (2022-11-01) -
CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
由: Ler Yie Chan, et al.
出版: (2022-03-01) -
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
由: John A. Ligon, et al.
出版: (2022-02-01) -
The Emergence of Universal Immune Receptor T Cell Therapy for Cancer
由: Nicholas G. Minutolo, et al.
出版: (2019-03-01)